Early Neonatal Presentation and Management of Diamond-Blackfan Anemia: A Case Report

Diamond-Blackfan anemia (DBA) is a rare congenital red cell aplasia that may present with severe anemia in early infancy.This report describes a case with very early neonatal presentation and a favorable hematologic response to corticosteroid therapy.A term male infant was presented at two days of life with marked pallor, feeding refusal, and severe anemia, with a hemoglobin level of 6.7 g/dL, requiring a red blood cell transfusion.After recurrent episodes of severe anemia, further investigation demonstrated macrocytosis, reticulocytopenia, and a normocellular bone marrow with rare erythroblasts, supporting the diagnosis of DBA.Oral prednisolone was initiated at one month 15 days of age and was associated with subsequent hematologic improvement, allowing gradual dose reduction.At the latest follow-up, the patient was 17 months old and had remained transfusion-independent for 14 months while receiving maintenance prednisolone.This case highlights the importance of considering DBA in neonates with unexplained severe anemia and reticulocytopenia, even in the absence of congenital anomalies.The hematologic response and sustained transfusion independence demonstrate a favorable clinical course following individualized management, with continued follow-up needed to assess long-term response and treatment safety.

Authors

Publication Details

Journal
Cureus
Published
2026-11-13
DOI
https://doi.org/10.7759/cureus.119602
Primary Topic
Blood disorders and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Early Neonatal Presentation and Management of Diamond-Blackfan Anemia: A Case Report

Henrique de Liz Arcari
Cureus
Blood disorders and treatments
article

Early Neonatal Presentation and Management of Diamond-Blackfan Anemia: A Case Report

Henrique de Liz Arcari
article en

Abstract

Diamond-Blackfan anemia (DBA) is a rare congenital red cell aplasia that may present with severe anemia in early infancy.This report describes a case with very early neonatal presentation and a favorable hematologic response to corticosteroid therapy.A term male infant was presented at two days of life with marked pallor, feeding refusal, and severe anemia, with a hemoglobin level of 6.7 g/dL, requiring a red blood cell transfusion.After recurrent episodes of severe anemia, further investigation demonstrated macrocytosis, reticulocytopenia, and a normocellular bone marrow with rare erythroblasts, supporting the diagnosis of DBA.Oral prednisolone was initiated at one month 15 days of age and was associated with subsequent hematologic improvement, allowing gradual dose reduction.At the latest follow-up, the patient was 17 months old and had remained transfusion-independent for 14 months while receiving maintenance prednisolone.This case highlights the importance of considering DBA in neonates with unexplained severe anemia and reticulocytopenia, even in the absence of congenital anomalies.The hematologic response and sustained transfusion independence demonstrate a favorable clinical course following individualized management, with continued follow-up needed to assess long-term response and treatment safety.

Cureus
Good health and well-being
Blood disorders and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon